Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.

Van Der Kraak L, Goel G, Ramanan K, Kaltenmeier C, Zhang L, Normolle DP, Freeman GJ, Tang D, Nason KS, Davison JM, Luketich JD, Dhupar R, Lotze MT.

J Immunother Cancer. 2016 Oct 18;4:65. eCollection 2016.

2.

A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.

Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):369-377.e3. doi: 10.1016/j.cgh.2015.10.020. Epub 2015 Oct 26.

3.

TissueCypher(™): A systems biology approach to anatomic pathology.

Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, Li J, Foxwell T, Taylor DL, Critchley-Thorne RJ.

J Pathol Inform. 2015 Aug 31;6:48. doi: 10.4103/2153-3539.163987. eCollection 2015.

4.

Paired exome analysis of Barrett's esophagus and adenocarcinoma.

Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, Davison JM, Nason KS, Loda M, Leshchiner I, Stewart C, Stojanov P, Seepo S, Lawrence MS, Ferrer-Torres D, Lin J, Chang AC, Gabriel SB, Lander ES, Beer DG, Getz G, Carter SL, Bass AJ.

Nat Genet. 2015 Sep;47(9):1047-55. doi: 10.1038/ng.3343. Epub 2015 Jul 20.

5.

The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.

Zahoor H, Luketich JD, Weksler B, Winger DG, Christie NA, Levy RM, Gibson MK, Davison JM, Nason KS.

Am J Surg. 2015 Oct;210(4):610-7. doi: 10.1016/j.amjsurg.2015.05.010. Epub 2015 Jun 26.

6.

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.

Derks S, Nason KS, Liao X, Stachler MD, Liu KX, Liu JB, Sicinska E, Goldberg MS, Freeman GJ, Rodig SJ, Davison JM, Bass AJ.

Cancer Immunol Res. 2015 Oct;3(10):1123-9. doi: 10.1158/2326-6066.CIR-15-0046. Epub 2015 Jun 16.

7.

Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.

Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM.

Am J Surg Pathol. 2015 Apr;39(4):487-95. doi: 10.1097/PAS.0000000000000356.

8.

Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Singhi AD, Seethala RR, Nason K, Foxwell TJ, Roche RL, McGrath KM, Levy RM, Luketich JD, Davison JM.

Hum Pathol. 2015 Mar;46(3):366-75. doi: 10.1016/j.humpath.2014.11.021. Epub 2014 Dec 17.

9.

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.

Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M, Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA.

Cancer. 2014 Dec 15;120(24):3902-13. doi: 10.1002/cncr.28963. Epub 2014 Aug 5.

10.

Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM.

Mod Pathol. 2014 Dec;27(12):1578-89. doi: 10.1038/modpathol.2014.66. Epub 2014 Apr 25.

11.

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Conrad KP, Davison JM.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1121-35. doi: 10.1152/ajprenal.00042.2014. Epub 2014 Mar 19. Review.

12.

The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.

Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA.

PLoS One. 2014 Jan 16;9(1):e79079. doi: 10.1371/journal.pone.0079079. eCollection 2014.

13.

MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.

Davison JM, Ellis ST, Foxwell TJ, Luketich JD, Gibson MK, Kuan SF, Nason KS.

Hum Pathol. 2014 Mar;45(3):540-8. doi: 10.1016/j.humpath.2013.10.020. Epub 2013 Oct 30.

14.

Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.

Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Irvin, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA.

PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013.

15.

Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish.

Thakur PC, Davison JM, Stuckenholz C, Lu L, Bahary N.

Dis Model Mech. 2014 Jan;7(1):93-106. doi: 10.1242/dmm.012864. Epub 2013 Oct 17.

16.

Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea.

Dreifuss SE, Tomizawa Y, Farber NJ, Davison JM, Sohnen AE.

Case Rep Gastrointest Med. 2013;2013:618071. doi: 10.1155/2013/618071. Epub 2013 Mar 13.

17.

Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.

Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donovan M, Dinjens WN, Biermann K, Shannon N, Worster S, Schulz LK, Luketich JD, Wijnhoven BP, Hardwick RH, Fitzgerald RC.

J Clin Oncol. 2013 Apr 20;31(12):1576-82. doi: 10.1200/JCO.2012.45.9636. Epub 2013 Mar 18.

18.

PET-CT confirms the diagnosis of pyogenic spondylodiscitis complicated by psoas abscess.

Davison JM, Graham JA, Nieves NM, Yoest SM.

BMJ Case Rep. 2013 Jan 23;2013. pii: bcr2012008264. doi: 10.1136/bcr-2012-008264. No abstract available.

19.

PET-CT aids in the diagnosis of a choroidal mass with retinal detachment in a patient with history of breast cancer and sarcoidosis.

Davison JM, Hotchkiss JH, Fadell AJ, Graham JA.

BMJ Case Rep. 2012 Mar 20;2012. pii: bcr1220115294. doi: 10.1136/bcr.12.2011.5294. No abstract available.

20.

HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.

Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM.

Am J Clin Pathol. 2012 Apr;137(4):583-94. doi: 10.1309/AJCPXQVS6YGHPDCY.

Supplemental Content

Loading ...
Support Center